Results 21 to 30 of about 51,904 (226)
Magnetic Activities of Wolf 359: Starspot Distribution and Quasiperiodic Pulsation Using TESS Data
Wolf 359 is the fifth closest (∼2.4 pc) star to Earth and a candidate exoplanet-hosting M6 dwarf. We studied the distribution of starspots and flaring activities of Wolf 359 to understand its stellar atmosphere and magnetic activities.
Diya Ram +3 more
doaj +1 more source
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE), but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung +6 more
wiley +1 more source
Double Tidal Disruption Events or Repeating Partial Tidal Disruption Events in AT 2020vdq
AT 2020vdq has been known as a candidate of repeating partial tidal disruption events (pTDEs) due to its two flares with a time interval of ∼1000 days.
XueGuang Zhang
doaj +1 more source
The Shape of M Dwarf Flares in Kepler Light Curves
Ultra-precise light curves from Kepler provide the best opportunity to determine rates and statistical properties of stellar flares. From 11 months of data on the active M4 dwarf, GJ 1243, we have built the largest catalog of flares for a single star ...
Davenport, James R. A.
core +1 more source
The JCMT Transient Survey: An Extraordinary Submillimetre Flare in the T Tauri Binary System JW 566 [PDF]
The binary T Tauri system JW 566 in the Orion Molecular Cloud underwent an energetic, short-lived flare observed at submillimetre wavelengths by the SCUBA-2 instrument on 26 November 2016 (UT).
Bell, Graham S. +9 more
core +4 more sources
Objective Although treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL ...
Austin Barry +16 more
wiley +1 more source
This paper presents a multiwavelength Sun-as-a-star analysis of the M8.7 flare on 2022 October 2, which was associated with a filament eruption and the subsequent coronal mass ejection.
Takato Otsu, Ayumi Asai
doaj +1 more source
Objective We aimed to identify unique disease trajectories within rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999 to 2021.
Bryant R. England +9 more
wiley +1 more source
Long‐Term Opioids in Gout: A Matched Cohort Study From the Veterans Health Administration
Objective Though used frequently to treat flare, risk of long‐term opioid exposure in gout has not been well defined. In this study, we examined the hypothesis that people with gout are more likely than individuals without gout to be prescribed long‐term opioids over time.
Lindsay N. Helget +7 more
wiley +1 more source
Objective The aim of this study was to investigate the cost‐effectiveness of low‐dose colchicine prophylaxis for preventing gout flares when starting allopurinol using the “start‐low go‐slow” approach. Methods Participants with gout, fulfilling the American College of Rheumatology recommendations for starting urate‐lowering therapy and with serum urate
Yana Pryymachenko +4 more
wiley +1 more source

